94502 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms; Two or more oxygen, sulphur or nitrogen atoms Three nitrogen atoms
COMPOUNDS HAVING N-ARYLPYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC AGENTS
#2HETEROCYCLIC COMPOUNDS AS E3 LIGASE INHIBITORS
#3SMALL MOLECULE INHIBITORS OF SRC TYROSINE KINASE
#4Methods for treating protozoan infections
#5Compositions and methods for treating infections
#6Autophagy modulators for use in treating cancer
#7Methods for treating protozoan infections
#8Methods for treating protozoan infections
#9APPLICATION OF 5-HT6 RECEPTOR ANTAGONISTS FOR THE ALLEVIATION OF COGNITIVE DEFICITS OF DOWN SYNDROME
#10Methods for treating protozoan infections
#11Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
#12Compounds and methods of treating infections
#13Compositions and methods for treating infections
#14Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
#15Pyrimidines and uses thereof
#16Intermediate of preparing high-purity sulfonamide compound
#17Method for preparing high-purity sulfonamide compound, and intermediate of sulfonamide compound
#18Methods for treating protozoan infections
#19Process for the preparation of triazolo[4,5-D] pyrimidine cyclopentane compounds
#20NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
#21Polymer film, retardation film, polarizing plate, liquid crystal display, and compound
#22Compounds and methods of treating infections
#23Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
#24Hair dye agent comprising aminopyrimidine derivatives
#25Compositions and methods for inhibition of the JAK pathway
#26Guanine riboswitch binding compounds and their use as antibiotics
#27Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
#28Piperazinyl pyrimidine derivatives, preparation method and use thereof
#29Method for synthesizing sapropterin dihydrochloride
#30Method for synthesizing sapropterin dihydrochloride
#31Polymer film, retardation film, polarizing plate, liquid crystal display, and compound
#32Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
#33Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
#34Application of 5-HTreceptor antagonists for the alleviation of cognitive deficits of down syndrome
#35Methods of making cocrystals
#361,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#37Rate-controlled particles
#38Platelet ADP receptor inhibitors
#39Compounds as respiratory stimulants for treatment of breathing control disorders or diseases
#40Pyrimidine derivative, preparation method and use thereof
#41GUANINE RIBOSWITCH BINDING COMPOUNDS AND THEIR USE AS ANTIBIOTICS
#42N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor
#43AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
#44Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#45Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#46PLATELET ADP RECEPTOR INHIBITORS
#47Pyrimidine derivative having cell protecting effect and uses thereof
#48Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound
#491,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#50USE OF SUBSTITUTED TRIS(DIPHENYLAMINO)TRIAZINE COMPOUNDS IN OLEDS
#51Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
#52Bis-aryl amide compounds and methods of use
#53Platelet ADP receptor inhibitors
#54TRIAMINOPYRIMIDINE CYCLOBUTENEDIONE DERIVATIVES USED AS PHOSPHATASE CDC25 INHIBITORS
#55Pyrimidine derivatives and their use for controlling undesired plant growth
#56Pyrimidine derivatives and their use for controlling undesired plant growth
#57Pyrimidine derivatives
#58PROCESS FOR PREPARING PURINE DERIVATIVE
#59SUBSTITUTED PYRIMIDINE DERIVATIVES
#60TRIAMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF CDC25 PHOSPHATASE
#61COMPOUNDS
#62Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
#63sEH inhibitors and their use
#64PROCESS FOR THE PREPARATION OF NITROGEN-CONTAINING COMPOUNDS
#65Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
#66Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#672-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
#68Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#69Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#70Heterocyclic compounds
#71Methods of identifying neuroprotective compounds for retinal ganglion cells
#72Use of Pyrimidine Compounds in the Preparation of Parasiticides
#73Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
#74RATE-CONTROLLED PARTICLES
#75HIV INHIBITING 2-(4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES
#76NOVEL PYRIMIDINE DERIVATIVES - 816
#77HIV inhibiting 5-substituted pyrimidines
#78Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives
#79Platelet ADP receptor inhibitors
#80Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#81Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
#82N-heterocyclic inhibitors of TNF-alpha expression
#83Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
#84HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines
#85Compositions and methods for inhibition of the JAK pathway
#86Pyrimidine derivatives
#87Use of pyrimidine compounds in the preparation of parasiticides
#88Platelet ADP receptor inhibitors
#89Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
#90Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
#91Bis-aryl amide compounds and methods of use
#92Substituted pyrimidine derivatives
#93N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor
#94Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins
#95Pyrimidine compounds
#96Pyrimidine compounds
#97N-heterocyclic inhibitors of TNF-α expression
#98N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
#991,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#100Platelet ADP receptor inhibitors
#101Piperazine compounds and medicinal use thereof
#102Heteroaryl compounds
#103Pyrimidine derivatives
#104Pyrimidine compounds, process for their preparation and compositions containing them
#105Pyridine compounds, process for their preparation and compositions containing them
#106Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
#107Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
#108Platelet ADP receptor inhibitors
#109Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
#110HIV inhibiting pyrimidine derivatives
#111HIV inhibiting pyrimidine derivatives
#112Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
#113Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
#114Pharmaceutical agents
#115Heteroaryl compounds which inhibit leukocyte adhesion mediated by αintegrins
#116Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins
#117Trisubstituted pyrimidines
#118Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
#119Novel anthelmintic and insecticidal compositions
#120Synthesis of aminopyrimidine-based energetic materials
#121Method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine and its application thereof